Effectiveness and safety of direct oral anticoagulants versus warfarin in obese patients with acute venous thromboembolism
JC Coons, L Albert, A Bejjani… - … : The Journal of Human …, 2020 - Wiley Online Library
… Therefore, the aim of this study was to evaluate the effectiveness and safety of DOACs
versus warfarin for the treatment of acute venous thromboembolism (VTE) in obese patients. …
versus warfarin for the treatment of acute venous thromboembolism (VTE) in obese patients. …
Safety and efficacy of dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: a randomized clinical trial
JM Ferro, JM Coutinho, F Dentali, A Kobayashi… - JAMA …, 2019 - jamanetwork.com
… of dabigatran and 2 among users of warfarin. Meaning This study suggests that both dabigatran
and dose-adjusted warfarin … venous thrombotic events in patients with cerebral venous …
and dose-adjusted warfarin … venous thrombotic events in patients with cerebral venous …
Comparative effectiveness and safety of apixaban versus warfarin in patients with venous thromboembolism
… effectiveness of apixaban versus warfarin for the prevention of recurrent VTE and (2) examine
the difference in major bleeding risk in patients with VTE receiving apixaban and warfarin. …
the difference in major bleeding risk in patients with VTE receiving apixaban and warfarin. …
[HTML][HTML] Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism …
MN Elshafei, MFH Mohamed, A El-Bardissy… - Journal of thrombosis …, 2021 - Springer
… However, their use in the treatment of acute venous thromboembolism (VTE) in morbidly
obese patients (bodyweight of > 120 kg or BMI > 40 kg/m 2 ) guarded. This is due to the scarce …
obese patients (bodyweight of > 120 kg or BMI > 40 kg/m 2 ) guarded. This is due to the scarce …
Multi‐center retrospective study evaluating the efficacy and safety of apixaban versus warfarin for treatment of venous thromboembolism in patients with severe …
A Crouch, TH Ng, D Kelley, T Knight… - … : The Journal of …, 2022 - Wiley Online Library
… These agents are recommended regardless of patient weight … the use of apixaban in patients
with severe obesity with a BMI … the efficacy and safety of apixaban for VTE in patients with a …
with severe obesity with a BMI … the efficacy and safety of apixaban for VTE in patients with a …
Real-World Effectiveness and Safety of Apixaban versus Warfarin in patients with acute venous thromboembolism: experience of a large tertiary hospital in Saudi …
… In the AMPLIFY trial, apixaban was non-inferior to warfarin in prevention … efficacy of apixaban
and warfarin in reducing risk of VTE recurrence, with lower risk of bleeding in the apixaban …
and warfarin in reducing risk of VTE recurrence, with lower risk of bleeding in the apixaban …
… safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a …
… Differences in the risk of recurrent venous thromboembolism and major … the effectiveness
and safety of apixaban and rivaroxaban in prevention of recurrent venous thromboembolism …
and safety of apixaban and rivaroxaban in prevention of recurrent venous thromboembolism …
Safety and effectiveness of dabigatran and other direct oral anticoagulants compared with warfarin in patients with atrial fibrillation
KF Huybrechts, C Gopalakrishnan… - Clinical …, 2020 - Wiley Online Library
The study objective was to evaluate the safety and effectiveness of dabigatran and other
direct oral anticoagulants (DOACs) compared with warfarin among patients with nonvalvular …
direct oral anticoagulants (DOACs) compared with warfarin among patients with nonvalvular …
Comparative effectiveness and safety of direct-acting oral anticoagulants and warfarin in patients with venous thromboembolism and active cancer: an observational …
… patients with venous thromboembolism (VTE) and active cancer. This study aimed to assess
the effectiveness of DOACs versus warfarin … events in patients with VTE and active cancer. …
the effectiveness of DOACs versus warfarin … events in patients with VTE and active cancer. …
Effectiveness and safety of direct oral anticoagulants vs. warfarin and recurrence after discontinuation in patients with acute venous thromboembolism in the real world
N Hara, T Lee, T Nozato, MT Matsuyama, S Okata… - Circulation …, 2022 - jstage.jst.go.jp
… Safety, effectiveness, and health care cost comparisons among elderly patients with
venous thromboembolism prescribed warfarin or apixaban in the United States Medicare …
venous thromboembolism prescribed warfarin or apixaban in the United States Medicare …